Using administrative medical claims data to supplement state disease registry systems for reporting zoonotic infections

Journal of the American Medical Informatics Association

Volumn 20, Issue 1, 2013, Pages 193-198

  Jones, Stephen G ^a   Coulter, Steven ^a   Conner, William ^b  

^a BlueCross BlueShield of Tennessee   (United States)

^b CLEMSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALIFORNIA ENCEPHALITIS; DISEASE REGISTRY; EHRLICHIOSIS; FEMALE; HEALTH INSURANCE; HUMAN; INCIDENCE; LYME DISEASE; MAJOR CLINICAL STUDY; MALE; MANAGED CARE ORGANIZATION; PIROPLASMOSIS; ROCKY MOUNTAIN SPOTTED FEVER; TULAREMIA; WEST NILE FEVER; ZOONOSIS;

ADULT; CHILD; DISEASE NOTIFICATION; ENCEPHALITIS, CALIFORNIA; FEMALE; HUMANS; INCIDENCE; INFORMATION DISSEMINATION; INSURANCE CLAIM REVIEW; LA CROSSE VIRUS; LINEAR MODELS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; POPULATION SURVEILLANCE; REGISTRIES; TENNESSEE; TICK-BORNE DISEASES; WEST NILE FEVER;

EID: 84871861030     PISSN: 10675027     EISSN: 1527974X     Source Type: Journal    
DOI: 10.1136/amiajnl-2012-000948     Document Type: Article

References (45)

1. Government Accountability Office (GAO). Emerging Infectious Diseases Review of State and Federal Disease Surveillance Efforts, Report to the Chairman, Permanent Subcommittee on Investigations, Committee on Governmental Affairs, US Senate. United States Government Accountability Office, 2004. GAO report# GAO-04e877. http://www.gao.gov/new.items/d04877.pdf
2. Centers for Disease Control and Prevention (CDC NNDSS). National Notifiable Diseases Surveillance System. 2010. http://www.cdc.gov/ncphi/disss/nndss/ nndsshis.htm (accessed 21 Sep 2010).
3. Koo D, Wetterhall SF. History and current status of the National Notifiable Diseases System. J Public Health Manag Pract 1996, 2, 4e10.
4. Tennessee Department of Health (TDH CEDS). Tennessee Department of Health, Communicable and Environmental Disease Services, Reportable Diseases and Events. 2010. http://health.state.tn.us/ceds/notifiable.htm (accessed 5 Oct 2010).
5. Doyle T, Glynn M, Groseclose S. Completeness of notifiable infectious disease reporting in the United States, an analytical literature review. Am J Epidemiol 2002, 155, 866e74.
6. Marier R. The reporting of communicable diseases. Am J Epidemiol 1977, 105, 587e90.
7. Meek J, Roberts C, Smith E Jr, et al. Underreporting of Lyme disease by Connecticut physicians. J Public Health Manag Pract 1996, 2, 61e5.
8. Koo D, Caldwell B. The role of providers and health plans in infectious disease surveillance. Eff Clin Pract 1999, 2, 247e52.
9. Figueiras A, Lado E, Fernández S, et al. Influence of physicians' attitude on undernotifying infectious diseases, a longitudinal study. Public Health 2004, 118, 521e6.
10. Young J. Underreporting of Lyme disease. N Engl J Med 1998, 338, 1629.
11. Campos-Outcalt D, England R, Porter B. Reporting of communicable diseases by university physicians. Public Health Rep 1991, 106, 579e83.
12. Office of the National Coordinator for Health Information Technology (ONC). Federal Health Information Technology Strategic Plan 2011e2015. Washington, DC, Office of the National Coordinator for Health Information Technology (ONC), 2011.
13. California Department of Public Health. Planning for Health Information Technology and Exchange in Public Health. UC Davis Health Informatics Seminar. 2009. http://www.cdph.ca.gov/programs/HISP/Documents/UCD-InformaticsSeminar-HIE-CDPH-0809-LScott.pdf
14. Rutherford GW. Public health, communicable diseases, and managed care, will managed care improve or weaken communicable disease control? Am J Prev Med 1998, 14(3 Suppl), 53e9.
15. Health Insurance Portability and Accountability Act (HIPAA) of 1996. U.S. Department of Health & Human Services, 1996. Pub. L. No. 104-191, 110 Stat. 1936. http://aspe. hhs.gov/admnsimp/pl104191.htm
16. DeNavas-Walt C, Proctor B, Smith J. US Census Bureau, Current population Reports, P60e238, Income, Poverty, and Health Insurance Coverage in the United States, 2009. Washington, DC, US Government Printing Office, 2010.
17. Centers for Disease Control and Prevention (CDC NCEZID). National Center for Emerging and Zoonotic Infectious Diseases. 2010. http://www.cdc.gov/ncezid/ (accessed 21 Sep 2010).
18. Tennessee Department of Health (TDH WebAim). Tennessee Department of Health, Communicable and Environmental Disease Services, The Communicable Disease Interactive Data Site. 2010. http://health.state.tn.us/Ceds/WebAim/ WEBAim_criteria.aspx
19. Salah A, Kamarianakis Y, Chlif S, et al. Zoonotic cutaneous leishmaniasis in central Tunisia, spatio-temporal dynamics. Int J Epidemiol 2007, 36, 991e1000.
20. SAS®. Statistical Analysis Software. Cary, NC, USA, Copyright © 2006-2008 by SAS Institute Inc, 2008.
21. Kalluri S, Gilruth P, Rogers D, et al. Surveillance of arthropod vector-borne infectious diseases using remote sensing techniques, a review. PLoS Pathog 2007, 3, 1361e71.
22. Wimberly MC, Baer AD, Yabsley MJ. Enhanced spatial models for predicting the geographic distributions of tick-borne pathogens. Int J Health Geogr 2008, 7, 15.
23. Winters AM, Eisen RJ, Lozano-Fuentes S, et al. Predictive spatial models for risk of West Nile virus exposure in eastern and western Colorado. Am J Trop Med Hyg 2008, 79, 581e90.
24. Yang K, Zhou XN, Wu XH, et al. Landscape pattern analysis and Bayesian modeling for predicting Oncomelania hupensis distribution in Eryuan County, People's Republic of China. Am J Trop Med Hyg 2009, 81, 416e23.
25. Yiannakoulias N, Schopflocher D, Svenson L. Using administrative data to understand the geography of case ascertainment. Chronic Dis Can 2009, 30, 20e8.
26. Centers for Disease Control and Prevention (CDC). Vaccine Safety Datalink (VSD) Project. http://www.cdc.gov/vaccinesafety/Activities/VSD.html
27. Marangoni A, Sparacino M, Cavrini F, et al. Comparative evaluation of three different ELISA methods for the diagnosis of early culture-confirmed Lyme disease in Italy. J Med Microbiol 2005, 54, 361e7.
28. Coyle BS, Strickland GT, Liang YY, et al. The public health impact of Lyme disease in Maryland. J Infect Dis 1996, 173, 1260e2.
29. Bacon RM, Kugeler KJ, Mead PS, Centers for Disease Control and Prevention (CDC). Surveillance for Lyme disease e United States, 1992e2006. MMWR Surveill Summ 2008, 57, 1e9.
30. Rosen M. Investigating the maintenance of the Lyme disease Pathogen, Borrelia burgdorferi, and Its Vector, Ixodes scapularis, in Tennessee. Master's Thesis, University of Tennessee, 2009. http://trace.tennessee.edu/utk_gradthes/554
31. Steere AC, Taylor E, McHugh GL, et al. The overdiagnosis of Lyme disease. JAMA 1993, 269, 1812e16.
32. Svenungsson B, Lindh G. Lyme borreliosisean overdiagnosed disease? Infection 1997, 25, 140e3.
33. Moncayo A. Vector-borne diseases in Tennessee. Tennessee Department of Health & Vanderbilt University Medical Center. Twenty Sixth Biennial State Public Health Vector Control Conference. 2006. http://www.cdc.gov/ncidod/dvbid/westnile/conf/ 26thbiennialVectorControl/pdf/state/Tennessee.pdf
34. Lacz N, Schwartz R, Kapila R. Rocky Mountain spotted Fever. MedScape eMedicine. http://emedicine.medscape.com/article/1054826-overview (accessed 1 Dec 2010).
35. Moncayo A, Cohen S, Fritzen C, et al. Absence of Rickettsia rickettsii and occurrence of other spotted fever group rickettsiae in ticks from Tennessee. Am J Trop Med Hyg 2010, 83, 653e7.
36. Georgia Epidemiology Report (GER). Common Tickborne Diseases in Georgia, Rocky Mountain Spotted Fever and Human Monocytic Ehrlichiosis. Georgia State Health Dept, Division of Public Health, 2004, 20, 5. http://health.state.ga.us/pdfs/epi/ gers/ger0504.pdf
37. Wilfert C, MacCormack J, Kleeman K, et al. Epidemiology of Rocky Mountain spotted fever as determined by active surveillance. J Infect Dis 1984, 150, 469e79.
38. Mosites E, Wheeler P, Pieniazek N, et al. Human babesiosis caused by a novel babesia parasiteeTennessee, 2009. International Conference on Emerging Infectious Diseases, Unpublished Abstract Presented at the International Conference on Emerging Infectious Disease (ICEID) July 2010 Atlanta, GA. 2010. http://www.iceid. org/images/stories/2010program.pdf
39. Moncayo A. Human Babesiosis. 2010 One Medicine Symposium, Reality Bites, A One Medicine Approach to Vector-Borne Diseases. 2010. http://www.ncagr.gov/ oep/oneMedicine/noms/2010/Moncayo_Abelardo_Human_Babesiosis.pdf
40. Hux JE, Ivis F, Flintoft V, et al. Diabetes in Ontario, determination of prevalence and incidence using a validated administrative data algorithm. Diabetes Care 2002, 25, 512e16.
41. Tu K, Campbell N, Chen X, et al. Accuracy of administrative databases in identifying patients with hypertension. Open Med 2007. http://www.openmedicine.ca/article/ view/17/23
42. Centers for Disease Control and Prevention (CDC). Notice to readers, recommendations for test performance and Interpretation from the Second National Conference on Serologic Diagnosis of Lyme disease. MMWR Morb Mortal Wkly Rep 1995, 44, 590e1.
43. Yiannakoulias L, Svenson LW. Differences between notifiable and administrative health information in the spatialetemporal surveillance of enteric infections. Int J Med Inform 2009, 78, 417e24.
44. Jones S, Conner W, Song B, et al. Comparing spatio-temporal clusters of arthropodborne infections using administrative medical claims and state reported surveillance data. Spat Spatiotemporal Epidemiol 2012, 3, 205e13.
45. Centers for Disease Control and Prevention (CDC). Case definitions for infectious conditions under public health surveillance, recommendations and reports. MMWR Recomm Rep 1997, 46, 1e55.